CVS Health Corporation (CVS) Financials
PeriodQ2 FY2026
Published
CVS Health reported $106.10 billion in total revenues for Q2 FY2026, the quarter ended June 30, 2026, up 7.3% from a year earlier, with growth in Health Care Benefits, Health Services and Pharmacy & Consumer Wellness. Net income attributable to CVS Health was $2.98 billion, up 191.8%, and diluted earnings per share were $2.31 against $0.80 a year earlier; operating income of $4.70 billion was up 97.5%, reflecting both better results across Health Care Benefits, Health Services and Pharmacy & Consumer Wellness and the absence of the legacy litigation charges recorded in the year-ago quarter. The insurance business accounted for much of the improvement, its medical benefit ratio coming in at 87.4%, down 2.5 points, helped by stronger Government performance and by the non-repeat of a prior-year Group Medicare Advantage premium deficiency reserve.
| Metric | Amount | vs. year ago |
|---|---|---|
| Revenue | $106,096,000,000 | up 7.3% |
| Net income | $2,979,000,000 | up 191.8% |
| Diluted EPS | $2.31 | up 188.8% |
| Operating income | $4,703,000,000 | up 97.5% |
| Medical benefit ratio | 87.4% | down 2.5 points |
Company details
| Name | CVS HEALTH Corp |
|---|---|
| Ticker | CVS |
| CIK | 0000064803 |
| Exchange | NYSE |
| State | Rhode Island |
| Incorporation | Delaware |
| SIC | 5912 |
| Office | Trade & Services |
| Industry | Retail-Drug Stores and Proprietary Stores |
| Latest period covered | Q2 FY2026, ended 2026-06-30, 10-Q, accession 0000064803-26-000098 |
| Fiscal year end | 12/31 (MM/DD) |
| Next expected filing | 10-Q around 2026-10-28 (predicted) |
Data files
- Financial statementsPage Annual financial statements plus the latest quarter: income statement, balance sheet, cash flow. Actual dollars, actual shares. Sourcing notes and uncertainties included.
- 10-K and 10-Q summaryPage Qualitative synthesis of the latest 10-K + 10-Q: business, risk factors (quarter-over-quarter changes flagged), MD&A, legal proceedings, subsequent events.
- 8-K filings and eventsPage Digest of material 8-K filings: earnings headlines, management changes, capital-return and financing actions, governance. SEC accession numbers cited throughout.
FAQ · CVS Health Q2 FY2026
How much revenue did CVS Health report in Q2 FY2026?
CVS Health reported $106.10 billion in total revenues for Q2 FY2026, the quarter ended June 30, 2026. That is up 7.3% from $98.92 billion in the same quarter a year earlier, with revenue higher in Health Care Benefits, Health Services and Pharmacy & Consumer Wellness.
What was CVS Health's net income in Q2 FY2026?
Net income attributable to CVS Health was $2.98 billion for Q2 FY2026, the quarter ended June 30, 2026, up 191.8% from $1.02 billion a year earlier. The increase came from improved performance in Health Care Benefits, Health Services and Pharmacy & Consumer Wellness and from the absence of the legacy litigation charges booked in the year-ago quarter, which were not deductible and had pushed the prior-year effective tax rate well above this quarter's.
What was CVS Health's earnings per share in Q2 FY2026?
CVS Health reported diluted earnings per share of $2.31 for Q2 FY2026, the quarter ended June 30, 2026, against $0.80 in the same quarter a year earlier.
Did CVS Health's medical benefit ratio improve in Q2 FY2026?
Yes. CVS Health's medical benefit ratio was 87.4% in Q2 FY2026, the quarter ended June 30, 2026, down 2.5 points from 89.9% a year earlier, which management attributed to better underlying Government business performance and to the absence of the prior year's Group Medicare Advantage premium deficiency reserve. A lower ratio means less of each premium dollar was spent on medical costs.
Where can I get CVS Health Corporation (CVS) financial data in machine-readable form?
Ticker Scout publishes CVS Health Corporation's financial statements as JSON at https://tickerscout.ai/cvs/financials.json, free, with no API key and no signup. The 10-K and 10-Q narrative and the 8-K events digest are published as Markdown at https://tickerscout.ai/cvs/narrative.md and https://tickerscout.ai/cvs/events.md. CVS Health Corporation's SEC CIK is 0000064803. Every figure cites the SEC accession number it came from, so it can be checked against sec.gov.
When does CVS Health Corporation (CVS) next file with the SEC?
CVS Health Corporation (CVS) is expected to file its next Form 10-Q with the SEC on or around October 28, 2026. That date is a projection rather than a company-announced date: it is derived from CVS Health Corporation's own filing history with the SEC, by taking the date the company filed the same fiscal period a year earlier and adding 52 weeks. The most recent periodic report on file is the 10-Q for Q2 FY2026, the period ended 2026-06-30, SEC accession 0000064803-26-000098.
How this page was built
This page was built from CVS Health Corporation's own filings with the SEC, read one at a time, and nothing on it is taken from a pre-tagged dataset, a data vendor or another website. The figures are on the company's own fiscal calendar and in actual dollars, as the filings report them. Where the filings do not support a figure, the record says so instead of reporting a zero; this period names four such gaps.
A single company files thousands of pages with the SEC in a year, and no two companies file them the same way, so the reading and the assembly here are done by AI rather than by rules that break on the differences. Every pass is then audited back against the filings it came from before the page is published, and anything the filings do not support is left out and named rather than filled in. AI can still make mistakes. That is why the accession numbers are printed: the filing is the authority, and this page is a route to it.
Published by Ticker Scout, an independent publisher of company filings data. About Ticker Scout · Disclaimer
Data extracted from SEC filings (accession numbers cited in each file). The undated URLs hold the latest period and are replaced in place each quarter; every period also stays published at its own dated URL, which never changes. Free to cite with attribution: Ticker Scout (tickerscout.ai). Not investment advice, see the Disclaimer.